We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+17.22%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$270M
AUM Growth
+$52.1M
Cap. Flow
+$22M
Cap. Flow %
8.14%
Top 10 Hldgs %
40.76%
Holding
941
New
464
Increased
200
Reduced
32
Closed
8

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.34M
2
XOM icon
ExxonMobil
XOM
+$1.31M
3
CVX icon
Chevron
CVX
+$1.25M
4
LLY icon
Eli Lilly
LLY
+$685K
5
JPM icon
JPMorgan Chase
JPM
+$684K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.18M
2
NVDA icon
NVIDIA
NVDA
+$618K
3
AVGO icon
Broadcom
AVGO
+$138K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$113K
5
AAPL icon
Apple
AAPL
+$105K

Sector Composition

Rank Sector Weight
1 Technology 44.15%
2 Healthcare 9.98%
3 Consumer Staples 7.57%
4 Financials 6.32%
5 Industrials 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$5.14T
$29.7M 11.01%
328,810
-8,520
-3% -$618K
AAPL icon
2
Apple
AAPL
$4.79T
$24.6M 9.11%
143,238
-579
-0.4% -$105K
MSFT icon
3
Microsoft
MSFT
$2.9T
$13.2M 4.89%
31,366
+1,013
+3% +$410K
AVGO icon
4
Broadcom
AVGO
$1.89T
$9.61M 3.56%
72,220
-1,110
-2% -$138K
SNPS icon
5
Synopsys
SNPS
$72.3B
$6.3M 2.34%
11,025
+188
+2% +$103K
SFM icon
6
Sprouts Farmers Market
SFM
$6.95B
$6.03M 2.24%
93,500
-300
-0.3% -$16.7K
FTNT icon
7
Fortinet
FTNT
$114B
$5.29M 1.96%
77,460
+135
+0.2% +$8.99K
ASML icon
8
ASML
ASML
$692B
$5.25M 1.95%
5,413
-3
-0.1% -$2.66K
COST icon
9
Costco
COST
$411B
$5.06M 1.88%
6,912
-3
-0% -$2.14K
ABBV icon
10
AbbVie
ABBV
$448B
$4.93M 1.83%
27,081
+269
+1% +$46.4K
MEDP icon
11
Medpace
MEDP
$15.1B
$4.42M 1.64%
10,936
-5
-0% -$1.76K
V icon
12
Visa
V
$672B
$3.97M 1.47%
14,211
+138
+1% +$38.1K
DOV icon
13
Dover
DOV
$28.9B
$3.87M 1.43%
21,821
+61
+0.3% +$9.82K
TSM icon
14
TSMC
TSM
$2.18T
$3.84M 1.42%
28,098
+44
+0.2% +$5.46K
ABB
15
DELISTED
ABB Ltd
ABB
$3.83M 1.42%
82,569
+114
+0.1% +$5.29K
TMO icon
16
Thermo Fisher Scientific
TMO
$196B
$3.77M 1.4%
6,490
+68
+1% +$38.2K
TGT icon
17
Target
TGT
$62.6B
$3.62M 1.34%
20,448
+304
+2% +$46.2K
TJX icon
18
TJX Companies
TJX
$172B
$3.56M 1.32%
35,064
+257
+0.7% +$24.9K
DHR icon
19
Danaher
DHR
$127B
$3.36M 1.24%
13,431
+10
+0.1% +$2.44K
EQIX icon
20
Equinix
EQIX
$101B
$3.22M 1.2%
3,907
ISRG icon
21
Intuitive Surgical
ISRG
$121B
$3.22M 1.19%
8,069
+28
+0.3% +$10.6K
PKG icon
22
Packaging Corp of America
PKG
$20.3B
$3.21M 1.19%
16,785
+55
+0.3% +$9.54K
AMZN icon
23
Amazon
AMZN
$2.63T
$3.11M 1.15%
17,227
+508
+3% +$84.8K
BLK icon
24
Blackrock
BLK
$164B
$3M 1.11%
3,593
-5
-0.1% -$4.02K
ADBE icon
25
Adobe
ADBE
$86.8B
$2.8M 1.04%
5,540
+339
+7% +$194K

Similar funds

Front Row Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Front Row Advisors held 941 positions worth $270M, up 24% from $218M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Front Row Advisors deployed $22M of net new capital in Q1 2024, opening 464 new positions and adding to 200 existing holdings. Its largest new stake was Vanguard Information Technology ETF: 8,008 shares worth $525K.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Pfizer, an estimated $1.18M trimmed.

  • Front Row Advisors's largest Q1 2024 buy was Vanguard Information Technology ETF: 8,008 shares worth $525K.
  • Front Row Advisors added most to Berkshire Hathaway Class B in Q1 2024, an estimated $1.34M increase.
  • Front Row Advisors's biggest Q1 2024 reduction was Pfizer, cutting an estimated $1.18M.
  • Front Row Advisors fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q1 2024, selling an estimated $16.2K.
  • Front Row Advisors's ten largest holdings make up 41% of its $270M portfolio in Q1 2024.
  • Front Row Advisors opened 464 new positions and closed 8 in Q1 2024.
  • Front Row Advisors's portfolio value rose 24% quarter-over-quarter to $270M.

Based on Front Row Advisors's 13F filing for Q1 2024, filed 14 May 2024.